HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Józef Kobos Selected Research
Józef Kobos Research Topics
Disease
15
Neoplasms (Cancer)
09/2023 - 01/2005
9
Laryngeal Neoplasms (Laryngeal Cancer)
04/2022 - 01/2003
4
Wilms Tumor (Wilm's Tumor)
11/2016 - 01/2008
3
Squamous Cell Carcinoma of Head and Neck
11/2020 - 01/2004
3
Hemangioma (Angioma)
11/2017 - 01/2016
3
Neoplasm Metastasis (Metastasis)
06/2016 - 01/2003
3
Neuroblastoma
02/2016 - 01/2007
2
Hypertension (High Blood Pressure)
07/2019 - 11/2015
2
Anaplasia
11/2016 - 01/2008
2
Disease Progression
06/2016 - 01/2007
2
Carcinogenesis
09/2014 - 01/2007
2
Allergic Rhinitis
04/2007 - 01/2006
2
Carcinoma (Carcinomatosis)
01/2007 - 01/2006
2
Hypersensitivity (Allergy)
01/2007 - 01/2006
1
Lip Neoplasms (Neoplasms, Lip)
09/2023
1
Urinary Bladder Neoplasms (Bladder Cancer)
05/2022
1
Edema (Dropsy)
07/2019
1
Ganglioneuroblastoma
01/2018
1
Hepatoblastoma
07/2016
1
Head and Neck Neoplasms (Head and Neck Cancer)
06/2016
1
Colonic Neoplasms (Colon Cancer)
06/2016
1
Rhabdomyosarcoma
12/2015
1
Endometrial Neoplasms (Endometrial Cancer)
09/2014
1
Endometrial Hyperplasia
09/2014
1
Pigmented Nevus (Melanocytic Nevus)
08/2013
1
Fetal Growth Retardation (Intrauterine Growth Retardation)
06/2012
1
Localized Scleroderma (Morphea)
01/2009
1
Systemic Scleroderma (Systemic Sclerosis)
01/2009
1
Fibrosis (Cirrhosis)
01/2009
1
Connective Tissue Diseases (Connective Tissue Disease)
01/2009
1
Nasal Polyps (Nasal Polyp)
01/2007
1
Hypertrophy
01/2006
1
Hypertrophic Pyloric Stenosis
01/2006
1
Bullous Pemphigoid (Pemphigoid)
01/2006
1
Rhinitis
01/2006
1
Pathologic Neovascularization
01/2006
1
Blister (Bulla)
01/2006
Drug/Important Bio-Agent (IBA)
10
Proteins (Proteins, Gene)
FDA Link
04/2022 - 01/2003
5
Nitrogen
IBA
09/2023 - 12/2015
5
Isotopes
IBA
05/2022 - 12/2015
4
Carbon
IBA
09/2023 - 07/2016
3
Propranolol (Inderal)
FDA Link
Generic
11/2017 - 01/2016
3
Biomarkers (Surrogate Marker)
IBA
11/2017 - 01/2007
3
Tissue Inhibitor of Metalloproteinase-2
IBA
06/2012 - 01/2007
3
Immunoglobulin E (IgE)
IBA
04/2007 - 01/2006
2
Sulfur
IBA
05/2022 - 07/2016
2
Cyclin D1
IBA
04/2022 - 01/2005
2
Metalloproteases (Metalloproteinases)
IBA
11/2017 - 01/2006
2
Complement System Proteins (Complement)
IBA
11/2017 - 11/2016
2
Matrix Metalloproteinases (MMPs)
IBA
11/2017 - 06/2016
2
Carbon Isotopes (Isotopes, Carbon)
IBA
11/2016 - 12/2015
2
Paraffin
IBA
02/2016 - 01/2005
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2016 - 01/2009
1
Carbon-13
IBA
05/2022
1
Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
IBA
01/2018
1
Messenger RNA (mRNA)
IBA
11/2017
1
Caspase 3 (Caspase-3)
IBA
01/2017
1
Nitrogen Isotopes (Isotopes, Nitrogen)
IBA
07/2016
1
Peptide Hydrolases (Proteases)
FDA Link
06/2016
1
Formaldehyde (Formol)
FDA Link
02/2016
1
Monoclonal Antibodies
IBA
02/2016
1
Antioxidants
IBA
11/2015
1
Vitamin E
FDA Link
Generic
11/2015
1
Ascorbic Acid (Vitamin C)
FDA Link
Generic
11/2015
1
Cyclin E
IBA
09/2014
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
06/2012
1
Tissue Inhibitor of Metalloproteinases
IBA
06/2012
1
Collagen
IBA
01/2009
1
Elements
IBA
01/2008
1
Indicators and Reagents (Reagents)
IBA
01/2008
1
WT1 Proteins
IBA
01/2008
1
Phosphopyruvate Hydratase (Enolase)
IBA
01/2008
1
Tissue Inhibitor of Metalloproteinase-3
IBA
01/2008
1
Coloring Agents (Dyes)
IBA
01/2008
1
Tissue Inhibitor of Metalloproteinase-1
IBA
01/2008
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
01/2007
1
Retinoblastoma Protein
IBA
01/2007
1
Antibodies
IBA
01/2007
1
Protein Isoforms (Isoforms)
IBA
01/2007
1
Fibronectins (Fibronectin)
IBA
01/2006
1
Glycoproteins (Glycoprotein)
IBA
01/2006
1
Thymidine Phosphorylase
IBA
01/2006
1
Antigens
IBA
01/2006
1
Autoantibodies
IBA
01/2006
1
Fas Ligand Protein (Fas Ligand)
IBA
01/2006
1
Enzymes
IBA
01/2006
1
Insulin (Novolin)
FDA Link
01/2006
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2006
1
DNA (Deoxyribonucleic Acid)
IBA
01/2005
1
beta Catenin
IBA
01/2004
1
Ki-67 Antigen (Ki 67 Antigen)
IBA
01/2003
Therapy/Procedure
3
Therapeutics
01/2017 - 01/2016
1
Aftercare (After-Treatment)
07/2019
1
Oral Administration
11/2015
1
Nephrectomy
01/2011
1
Laryngectomy
01/2005